Drug comparisons
Canagliflozin vs Pramlintide
Compare Canagliflozin (Invokana) vs Pramlintide (Symlin) – oral SGLT2 inhibitor vs injectable amylin analog for type 2 diabetes management and safety.
No comparison dimensions are available for this page.
Clinical context
This comparison arises for type 2 diabetes patients considering oral SGLT2 inhibitors versus injectable amylin analogs as add-on therapy, especially those on insulin.
Bottom line
Canagliflozin is typically preferred for convenience and extra benefits in type 2 diabetes, while Pramlintide fills a niche for insulin-treated patients; choice is individualized.
All medication comparisons